TMEM41B (Transmembrane Protein 41B) antibodies are biological tools designed to detect and study the expression, localization, and functional roles of the TMEM41B protein. This endoplasmic reticulum (ER)-resident protein regulates autophagy, lipid mobilization, and viral replication. Antibodies targeting TMEM41B enable researchers to investigate its involvement in cellular processes such as lipid droplet dynamics, autophagosome formation, and host-pathogen interactions .
Coronaviruses and Flaviviruses: TMEM41B antibodies confirmed its role as a critical host factor for SARS-CoV-2, HCoV-229E, Zika virus (ZIKV), and dengue virus (DENV). Knockout studies using TMEM41B-specific shRNAs reduced viral replication by >80% .
Mechanistic Insights: Antibodies helped demonstrate TMEM41B’s involvement in forming viral replication organelles (e.g., double-membrane vesicles for coronaviruses) and regulating lipid-dependent clathrin-coated pit dynamics during viral entry .
Lipid Droplet Dynamics: TMEM41B antibodies identified enlarged lipid droplets in TMEM41B-deficient cells, linking the protein to fatty acid mobilization and β-oxidation .
ER Scramblase Activity: Studies using these antibodies revealed TMEM41B’s role as a phospholipid scramblase, essential for maintaining lipid bilayer homeostasis .
Interferon-Stimulated Gene (ISG): TMEM41B antibodies verified its induction by interferon-γ, highlighting its dual role as a proviral factor and immune modulator .
Knockout Validation: Commercially available antibodies (e.g., Cell Signaling #68071) showed no cross-reactivity in TMEM41B-knockout cell lines, confirming specificity .
siRNA Knockdown: Abcam’s ab314763 demonstrated reduced signal intensity in siRNA-treated 293T cells, correlating with TMEM41B mRNA depletion .
Cross-Species Reactivity: Proteintech’s 29270-1-AP detects TMEM41B in human and mouse tissues, enabling comparative studies .
Isoform Diversity: TMEM41B has four splicing variants, but only isoform 1 (full-length VTT domain) supports viral replication. Commercial antibodies may not distinguish all isoforms .
Background Staining: Some antibodies (e.g., Sigma-Aldrich HPA014946) exhibit nonspecific signals in immunohistochemistry, requiring optimization .
TMEM41B antibodies are pivotal for developing therapeutics targeting viral replication organelles and lipid metabolism. Ongoing research focuses on:
TMEM41B (transmembrane protein 41B), also known as Stasimon, is a six-transmembrane domain protein that localizes to the endoplasmic reticulum. It has emerged as a critical factor in multiple biological processes, including autophagosome biogenesis, lipid mobilization, and viral replication. TMEM41B has been identified as a major target of survival motor neuron (SMN)-dependent U12 splicing and is required for motor circuit function . Its calculated molecular weight is 32 kDa, though it is typically observed at 22-28 kDa in experimental conditions . The protein has gained significant research interest after being identified as a crucial host factor required for the replication of diverse coronaviruses, including SARS-CoV-2 . Studies of TMEM41B provide insights into fundamental cellular processes and potential therapeutic targets for viral infections.
The TMEM41B antibody (29270-1-AP) has been validated for multiple experimental applications, as demonstrated in published literature. The primary applications include:
| Application | Validation Status | Publication Support |
|---|---|---|
| Western Blot (WB) | Validated | 4 publications cited |
| Immunohistochemistry (IHC) | Validated | 1 publication cited |
| Immunofluorescence (IF) | Validated | 2 publications cited |
| ELISA | Validated | Not specified in publications |
| Knockdown/Knockout Verification | Validated | 3 publications cited |
Optimal dilution ranges have been established for different applications:
| Application | Recommended Dilution |
|---|---|
| Western Blot (WB) | 1:1000-1:6000 |
| Immunohistochemistry (IHC) | 1:50-1:500 |
It is important to note that the optimal dilution may be sample-dependent. Researchers are recommended to titrate the antibody in each testing system to obtain optimal results . For immunohistochemistry applications, antigen retrieval with TE buffer pH 9.0 is suggested, though citrate buffer pH 6.0 may also be used as an alternative .
For Western blot applications, A549 cells and HeLa cells have been confirmed as positive controls that express detectable levels of TMEM41B . For immunohistochemistry, mouse lung tissue, mouse testis tissue, and human lung tissue have been validated as positive controls . When establishing knockout validation controls, researchers should be aware that commercially available antibodies may show background staining in knockout lines, necessitating careful experimental design and interpretation .
Validating TMEM41B knockout or knockdown requires a multi-faceted approach due to challenges with antibody specificity. Successful validation strategies include:
Due to challenges with antibody specificity for endogenous TMEM41B, several approaches have proven effective for studying its subcellular localization:
Fluorescent protein tagging: Both N- and C-terminal fusions of eGFP to TMEM41B have been successfully used to monitor localization. These constructs showed a reticular pattern characteristic of ER localization, with higher expression in the perinuclear region compared to the cell periphery . Functionality of these constructs can be verified by complementation assays in knockout cell lines .
Epitope tagging of endogenous loci: CRISPR-mediated knock-in of tags (e.g., Myc epitope) at the C-terminus of endogenous TMEM41B provides a more physiological approach to visualization. This method has confirmed robust co-localization with the ER marker calnexin .
Co-localization studies: When visualizing TMEM41B, co-staining with ER markers like calnexin or KDEL has shown high but not complete co-localization, helping to define its specific subdomain within the ER .
To investigate TMEM41B's role in autophagy, researchers have successfully employed several methodologies:
Monitoring autophagy markers: Analysis of autophagy cargo receptors (p62, NDP52) in TMEM41B-depleted cells under basal and activated autophagy conditions reveals defects in autophagosome biogenesis .
Autophagosome formation assays: Comparing the formation and maturation of autophagosomes in control versus TMEM41B knockout cells using markers such as LC3 can demonstrate TMEM41B's role in this process .
Genetic complementation: Reintroduction of wild-type TMEM41B into knockout cells to rescue autophagy defects confirms the specificity of the observed phenotypes .
Interaction proteomics: Immunoprecipitation of tagged TMEM41B followed by mass spectrometry has identified interactions with components of the COPI complex and other ER proteins, providing insights into its molecular mechanism .
TMEM41B knockout cells display distinct lipid metabolism phenotypes that can be quantitatively assessed:
TMEM41B knockout impacts cellular metabolism in several measurable ways:
Decreased mitochondrial respiration: TMEM41B-depleted cells display a small but significant decrease in basal mitochondrial oxygen consumption .
Increased glycolysis: Extracellular acidification rates are increased in TMEM41B knockout cells, suggesting that they may have increased glycolysis to compensate for defects in mitochondrial respiration .
Reduced β-oxidation: By measuring oxygen consumption in the presence or absence of etomoxir (an inhibitor of mitochondrial fatty acid import), studies have demonstrated that TMEM41B-deficient cells have significantly lower endogenous fatty acid utilization rates .
ER structure alterations: As an ER-resident protein, TMEM41B deficiency may alter ER morphology or function, which in turn affects lipid metabolism pathways .
Multiple experimental approaches have established TMEM41B as a critical host factor for coronavirus replication:
Genome-wide screening: A genome-wide host-dependency factor screen with HCoV-229E identified TMEM41B as the highest magnitude hit with an unknown function during infection .
CRISPR validation: Targeted CRISPR-Cas9 knockout of TMEM41B provided protection from cytopathic effects during coronavirus infection and significantly reduced viral RNA levels .
RNAi confirmation: siRNA-mediated knockdown of TMEM41B in multiple cell types confirmed significant reduction in viral infection levels, demonstrating that the requirement for TMEM41B is not cell type specific .
Cross-species validation: The requirement for TMEM41B is conserved across coronaviruses from different genera, including HCoV-229E, SARS-CoV-2, and PDCoV, suggesting it as a potential broad-spectrum target .
Time-course experiments with knockout cell lines have provided insights into when TMEM41B functions during viral infection:
Early replication block: Despite similar or higher viral RNA levels at 1 hour post-infection (representing initial viral inoculum), viral replication was undetectable during the first 10 hours of infection in TMEM41B knockout cell lines .
Replication complex formation: TMEM41B is believed to be involved in the formation of ER-derived viral replication complexes, which are essential for coronavirus replication .
Lipid trafficking role: Research suggests that TMEM41B controls lipid trafficking, which is important for virally-induced replication complex formation rather than serving as a structural component of these complexes .
Distinct from viral entry: The experimental data indicates that TMEM41B is not required for viral genomic release from the endosome but rather functions at subsequent stages of replication .
Several experimental approaches have proven effective for studying TMEM41B's function in viral infection:
Viral RNA quantification: RT-qPCR to measure viral RNA levels at different time points post-infection in control versus TMEM41B-depleted cells .
Viral titer determination: Quantifying infectious virus production through plaque assays or TCID50 assays .
Cytopathic effect monitoring: Assessing cell viability over infection time courses to determine if TMEM41B loss blocks initial infection or viral spread .
Confocal microscopy: Visualizing the relationship between TMEM41B and viral replication complexes using markers such as double-stranded RNA (dsRNA) .
Complementation studies: Reintroduction of TMEM41B into knockout cells to rescue viral replication, confirming the specificity of the observed phenotypes .